Posttransplant recurrence of proteinuria in a case of focal segmental glomerulosclerosis associated with WT1 mutation

American Journal of Transplantation

Volumn 6, Issue 9, 2006, Pages 2208-2211

  Ghiggeri, G M ^a   Aucella, F ^b   Caridi, G ^a   Bisceglia, L ^b   Ghio, L ^c   Gigante, M ^d   Perfumo, F ^a   Carraro, M ^e   Gesualdo, L ^d  

^a G GASLINI INSTITUTE   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^c Transplant Unit   (Italy)

^d UNIVERSITY OF FOGGIA   (Italy)

^e UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Frasier syndrome; FSGS; Posttransplant recurrence; Rephrotic syndrome; WT1 mutations

Indexed keywords

ALBUMIN; SERUM ALBUMIN;

ADOLESCENT; ARTICLE; CASE REPORT; FEMALE; FOCAL GLOMERULOSCLEROSIS; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; FRASIER SYNDROME; GENE; GENE MUTATION; GRAFT RECIPIENT; HEREDITY; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY GRAFT; NEPHROTIC SYNDROME; NPHS2 GENE; PATHOGENESIS; PLASMA; PLASMAPHERESIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEINURIA; RECURRENT DISEASE; TREATMENT OUTCOME; WT1 GENE;

ADOLESCENT; FEMALE; GENOTYPE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY TRANSPLANTATION; MUTATION; PLASMAPHERESIS; POSTOPERATIVE COMPLICATIONS; PROTEINURIA; RECURRENCE; WT1 PROTEINS;

EID: 33746882819     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01418.x     Document Type: Article

References (22)

1. Bonilla-Felix M, Parra C, Dajani T et al. Changing patterns in the histopathology of idiopathic nephrotic syndrome in children. Kidney Int 1999; 55: 1885-1890.
2. Artero M, Biava C, Amend W, Tomlanovich S, Vincenti F. Recurrent focal glomerulosclerosis: Natural history and response to therapy. Am J Med 1992; 92: 375-383.
3. Dall'Amico R, Ghiggeri G, Carraro M et al. Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children. Am J Kidney Dis 1999; 34: 1048-1055.
4. Weber S, Tonshoff B. Recurrence of focal-segmental glomerulosclerosis in children after renal transplantation: Clinical and genetic aspects. Transplantation 2005; 80(1 Suppl): S128-S134.
5. Vincenti F, Ghiggeri GM. New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis. Am J Transplant 2005; 5: 1179-1185.
6. Broyer M, Selwood N, Brunner F. Recurrence of primary renal disease on kidney graft: A European pediatric experience. J Am Soc Nephrol 1992; 2(12 Suppl): S255-S257.
7. Tejani A, Stablein DH. Recurrence of focal segmental glomerulosclerosis posttransplantation: A special report of the North American Pediatric Renal Transplant Cooperative Study. J Am Soc Nephrol 1992; 2(12 Suppl): S258-S263.
8. Artero ML, Sharma R, Savin VJ, Vincenti F. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 1994; 23: 574-581.
9. Dantal J, Bigot E, Bogers W et al. Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 1994; 330: 7-14.
10. Savin VJ, Sharma R, Sharma M et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl JMed 1996; 334: 878-883.
11. Coward RJ, Foster RR, Patton D et al. Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin, Podocin, and CD2 associated protein in cultured human podocytes. J Am Soc Nephrol 2005; 16: 629-637.
12. Doublier S, Musante L, Lupia E et al. Direct effect of plasma permeability factors from patients with idiopatic FSGS on nephrin and podocin expression in human podocytes. Int J Mol Med 2005; 16: 49-58.
13. Bertelli R, Ginevri F, Caridi G et al. Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. Am J Kidney Dis 2003; 41: 1314-1321.
14. Caridi G, Perfumo F, Ghiggeri GM. NPHS2 (Podocin) mutations in nephrotic syndrome. Clinical spectrum and fine mechanisms. Pediatr Res 2005; 57(5 Pt 2): 54R-61R.
15. Ruf RG, Lichtenberger A, Karle SM et al. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol 2004; 15: 722-732.
16. Weber S, Gribouval O, Esquivel EL et al. NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney Int 2004; 66: 571-579.
17. Carraro M, Caridi G, Bruschi M et al. Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid- resistantnephrotic syndrome. J AmSoc Nephrol 2002; 13: 1946-1952.
18. Ghiggeri GM, Catarsi P, Scolari F et al. Cyclosporine in patients with steroid-resistant nephrotic syndrome: An open-label, nonrandomized, retrospective study. Clin Ther 2004; 26: 1411-1418.
19. Savin VJ, Sharma R, Lovell HB, Welling DJ. Measurement of albumin reflection coefficient with isolated rat glomeruli. J Am Soc Nephrol 1992; 3: 1260-1269.
20. Baird PN, Santos A, Groves N, Jadresic L, Cowell JK. Constitutional mutations in the WT1 gene in patients with Denys-Drash syndrome. Hum Mol Genet 1992; 1: 301-305.
21. Mucha B, Ozaltin F, Hinkes BG et al. Mutations in the Wilms' tumor 1 gene cause isolated steroid resistant nephrotic syndrome and occur in exons 8 and 9. Pediatr Res 2006; 59: 325-331.
22. Candiano G, Musante L, Carraro M et al. Apolipoproteins prevent glomerular albumin permeability induced in vitro by serum from patients with focal segmental glomerulosclerosis. J Am Soc Nephrol 2001; 12: 143-150.